472 related articles for article (PubMed ID: 34029952)
21. Carnosic acid protects against doxorubicin-induced cardiotoxicity through enhancing the Nrf2/HO-1 pathway.
Hu S; Liu B; Yang M; Mao S; Ju H; Liu Z; Huang M; Wu G
Food Funct; 2023 Apr; 14(8):3849-3862. PubMed ID: 37013966
[TBL] [Abstract][Full Text] [Related]
22. Ameliorative Effect of Cardamom Aqueous Extract on Doxorubicin-Induced Cardiotoxicity in Rats.
Abu Gazia M; El-Magd MA
Cells Tissues Organs; 2018; 206(1-2):62-72. PubMed ID: 30716735
[TBL] [Abstract][Full Text] [Related]
23. Effect of ghrelin on VEGF-B and connexin-43 in a rat model of doxorubicin-induced cardiomyopathy.
Elhadidy MG; Elmasry A; Rabei MR; Eladel AE
J Basic Clin Physiol Pharmacol; 2019 Nov; 31(1):. PubMed ID: 31730522
[TBL] [Abstract][Full Text] [Related]
24. β2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways.
Fajardo G; Zhao M; Berry G; Wong LJ; Mochly-Rosen D; Bernstein D
J Mol Cell Cardiol; 2011 Nov; 51(5):781-9. PubMed ID: 21756913
[TBL] [Abstract][Full Text] [Related]
25. Epigallocatechin-3-gallate pretreatment attenuates doxorubicin-induced cardiotoxicity in rats: A mechanistic study.
Saeed NM; El-Naga RN; El-Bakly WM; Abdel-Rahman HM; Salah ElDin RA; El-Demerdash E
Biochem Pharmacol; 2015 Jun; 95(3):145-55. PubMed ID: 25701654
[TBL] [Abstract][Full Text] [Related]
26. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
Zhang QL; Yang JJ; Zhang HS
Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
[TBL] [Abstract][Full Text] [Related]
27. The role of hesperidin as a cardioprotective strategy against doxorubicin-induced cardiotoxicity: The antioxidant, anti-inflammatory, antiapoptotic, and cytoprotective potentials.
Alharbi FK; Alshehri ZS; Alshehri FF; Alhajlah S; Khalifa HA; Dahran N; Ghonimi WAM
Open Vet J; 2023 Dec; 13(12):1718-1728. PubMed ID: 38292716
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway.
Du J; Hang P; Pan Y; Feng B; Zheng Y; Chen T; Zhao L; Du Z
Toxicol Appl Pharmacol; 2019 Apr; 369():73-81. PubMed ID: 30831132
[TBL] [Abstract][Full Text] [Related]
29. Chitosan oligosaccharides prevent doxorubicin-induced oxidative stress and cardiac apoptosis through activating p38 and JNK MAPK mediated Nrf2/ARE pathway.
Zhang Y; Ahmad KA; Khan FU; Yan S; Ihsan AU; Ding Q
Chem Biol Interact; 2019 May; 305():54-65. PubMed ID: 30928397
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy.
Xia P; Liu Y; Chen J; Coates S; Liu DX; Cheng Z
J Biol Chem; 2018 Dec; 293(51):19672-19685. PubMed ID: 30361442
[TBL] [Abstract][Full Text] [Related]
31. SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function.
Wang P; Wang L; Lu J; Hu Y; Wang Q; Li Z; Cai S; Liang L; Guo K; Xie J; Wang J; Lan R; Shen J; Liu P
J Mol Cell Cardiol; 2019 Aug; 133():125-137. PubMed ID: 31199952
[TBL] [Abstract][Full Text] [Related]
32. Promising cardioprotective effect of baicalin in doxorubicin-induced cardiotoxicity through targeting toll-like receptor 4/nuclear factor-κB and Wnt/β-catenin pathways.
El-Ela SRA; Zaghloul RA; Eissa LA
Nutrition; 2022 Oct; 102():111732. PubMed ID: 35816809
[TBL] [Abstract][Full Text] [Related]
33. Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats.
Wan Y; He B; Zhu D; Wang L; Huang R; Zhu J; Wang C; Gao F
Arch Biochem Biophys; 2021 Nov; 712():109050. PubMed ID: 34610336
[TBL] [Abstract][Full Text] [Related]
34. In Vivo Protective Effects of Diosgenin against Doxorubicin-Induced Cardiotoxicity.
Chen CT; Wang ZH; Hsu CC; Lin HH; Chen JH
Nutrients; 2015 Jun; 7(6):4938-54. PubMed ID: 26091236
[TBL] [Abstract][Full Text] [Related]
35. Proanthocyanidin alleviates doxorubicin-induced cardiac injury by inhibiting NF-kB pathway and modulating oxidative stress, cell cycle, and fibrogenesis.
Sadek KM; Mahmoud SFE; Zeweil MF; Abouzed TK
J Biochem Mol Toxicol; 2021 Apr; 35(4):e22716. PubMed ID: 33484087
[TBL] [Abstract][Full Text] [Related]
36. Citronellal alleviates doxorubicin-induced cardiotoxicity by suppressing oxidative stress and apoptosis via Na
Liu X; Qiu Y; Huang N; Liu YH; Wang HH; Yu YN; Song YT; Wan GR; Wang SX; Li P; Yin YL
J Biochem Mol Toxicol; 2022 Mar; 36(3):e22971. PubMed ID: 34813134
[TBL] [Abstract][Full Text] [Related]
37. Melatonin attenuates doxorubicin-induced cardiotoxicity through preservation of YAP expression.
Li HR; Wang C; Sun P; Liu DD; Du GQ; Tian JW
J Cell Mol Med; 2020 Mar; 24(6):3634-3646. PubMed ID: 32068341
[TBL] [Abstract][Full Text] [Related]
38. α-Linolenic acid attenuates doxorubicin-induced cardiotoxicity in rats through suppression of oxidative stress and apoptosis.
Yu X; Cui L; Zhang Z; Zhao Q; Li S
Acta Biochim Biophys Sin (Shanghai); 2013 Oct; 45(10):817-26. PubMed ID: 23896563
[TBL] [Abstract][Full Text] [Related]
39. Dexmedetomidine alleviates doxorubicin cardiotoxicity by inhibiting mitochondrial reactive oxygen species generation.
Yu JL; Jin Y; Cao XY; Gu HH
Hum Cell; 2020 Jan; 33(1):47-56. PubMed ID: 31643023
[TBL] [Abstract][Full Text] [Related]
40. Nerolidol, a Sesquiterpene from the Essential Oils of Aromatic Plants, Attenuates Doxorubicin-Induced Chronic Cardiotoxicity in Rats.
Meeran MFN; Azimullah S; Mamoudh HH; Sharma C; Kumar S; Goyal SN; Ojha S
J Agric Food Chem; 2021 Jul; 69(26):7334-7343. PubMed ID: 34170670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]